ACC Annual Scientific Sessions 2027
American College of Cardiology — ACC.27
About ACC.27
The ACC Annual Scientific Sessions (ACC.27) is the premier cardiovascular conference in North America, convening over 15,000 cardiologists, pharmacists, nurses, and researchers from more than 140 countries. The 2027 meeting at McCormick Place in Chicago marks the 76th annual gathering of the American College of Cardiology.
ACC.27 runs concurrently with the World Congress of Cardiology (WCC), drawing international experts and providing a truly global perspective on cardiovascular science. Sessions span interventional cardiology, heart failure, electrophysiology, preventive cardiology, pharmacotherapy, and imaging — many of which directly update the ACC/AHA clinical practice guidelines.
Late-Breaking Clinical Trials
The four LBCT sessions are the centrepiece of every ACC meeting. Results are embargoed until the moment of oral presentation, then published simultaneously — usually in the New England Journal of Medicine, JAMA, or The Lancet.
PCI vs CABG in complex disease, antithrombotic de-escalation strategies, high-sensitivity troponin algorithms, TAVR long-term outcomes, and structural heart trials.
SGLT2 inhibitor real-world registries, novel HFpEF pharmacotherapies, cardiac amyloid treatments (tafamidis long-term), and device-based therapies.
Inclisiran real-world outcomes, PCSK9 inhibitor head-to-head, GLP-1 RA cardiovascular trials, BP targets in high-risk populations, and polypill primary prevention.
Catheter ablation vs antiarrhythmic drug therapy in AF, pulse-field ablation registries, factor Xa inhibitor switching studies, and cardiac monitoring for occult AF detection.
Abstracts and trial results are published in Journal of the American College of Cardiology (JACC) concurrent with ACC.27 presentations.
Pharmacology at ACC.27
ACC.27 features dedicated pharmacology programming relevant to clinical pharmacists and cardiology pharmacists:
Programme Overview
| Day | Date | Highlights |
|---|---|---|
| Sunday | Mar 29 | Pre-conference courses · Interventional cardiology hands-on · Opening plenary · Welcome reception |
| Monday | Mar 30 | LBCT I & II · Guideline update sessions · Innovation showcase · Named lectures · Industry symposia |
| Tuesday | Mar 31 | LBCT III & IV · Research posters · Quality improvement workshop · Closing plenary |
Practical Information
Member from ~$695
Non-member from ~$1,195
Fellow-in-training/student reduced rate
All LBCT sessions live-streamed; on-demand content available for 90 days post-conference.
Up to 20 AMA PRA Category 1 Credits™; pharmacy CME per ACPE reciprocity.
FAQ
When and where is ACC.27?
March 29–31, 2027 at McCormick Place, Chicago, IL. Virtual access is available with live-streaming of LBCT sessions and on-demand content.
What are Late-Breaking Clinical Trials at ACC?
LBCT sessions present the first public results of pivotal cardiovascular trials, usually simultaneously published in major journals (NEJM, JAMA, Lancet). They are often the most influential sessions for clinical practice change.
How does ACC.27 differ from AHA Scientific Sessions?
ACC.27 (March) emphasises interventional cardiology, coronary disease, and clinical practice. AHA Scientific Sessions (November) has a stronger basic/translational science and heart failure emphasis. Both present LBCT and guideline updates.
Can pharmacists earn CME/CPE at ACC.27?
ACC.27 offers AMA PRA Category 1 CME credits. Pharmacists may access pharmacotherapy-specific CME content; check the ACC registration page for current ACPE-accredited offerings.